IL-6 is often upregulated in epithelial cancers, such as breast and prostate [31, 32] and the IL-6/STAT3 axis is often considered as part of a positive regulatory circuit operating in inflammatory setting to nourish cancer cells and allow to maintain their transformed phenotypes [15]. This evidence concerns the gene IL6 and cancer.